Kallmann Syndrome (KS) is a genetic disorder that affects sexual development and the sense of smell. The condition is characterized by delayed or absent puberty (hypogonadism) and anosmia or hyposmia (lack or reduction of smell). It affects both males and females, though males are diagnosed more often.
Genetic Mutations:
Kallmann Syndrome is caused by mutations in specific genes, including KAL1, FGFR1, and PROK2, which affect the development of the olfactory system and hypothalamus during embryogenesis.
Delayed Puberty:
Anosmia (Loss of Smell):
The lack of migration of gonadotropin-releasing hormone (GnRH) neurons from the olfactory bulb to the hypothalamus results in hormonal deficiencies that prevent normal puberty.
Hormonal Testing:
Genetic Testing:
Hormone Replacement Therapy (HRT):
With proper treatment, individuals with Kallmann Syndrome can lead normal lives, although fertility treatment may be required for those wishing to have children.
